Cyprus vs Sur: Previously treated cases tested for RR-/MDR-TB
Cyprus
100.0%
in 2023
Sur
62.0%
in 2024
Cyprus rank
1st
Sur rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Cyprus
- Sur
How they compare
Cyprus currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Cyprus's figure about 1.6 times Sur's.
The two have swapped places 4 times across 15 shared years of data; in 2005 it was Sur ahead.
Cyprus ranks 1st and Sur ranks 1st of 180 countries.
Cyprus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cyprus | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 55.7% | 14.3% | 41.3% | Cyprus |
| 2010s | 59.1% | 54.6% | 4.5% | Cyprus |
| 2020s | 100.0% | 82.5% | 17.5% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cyprus or Sur?
- Cyprus, at 100.0% against 62.0% in Sur as of 2023.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cyprus and Sur?
- 38.0%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Sur?
- 15 years are reported by both, from 2005 to 2023.
- How do Cyprus and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Cyprus ranks 1st and Sur ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.